Status:
COMPLETED
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
Lead Sponsor:
AstraZeneca
Conditions:
Acute Coronary Syndromes
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
Eligibility Criteria
Inclusion
- Non-ST segment elevation ACS and ST segment elevation ACS who receive optimal reperfusion therapy
Exclusion
- Previous Q-wave infarct within the last 4 weeks
- CK elevation not caused by myocardial injury
- uncontrolled hypertension at time of randomization
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
825 Patients enrolled
Trial Details
Trial ID
NCT00214630
Start Date
December 1 2003
End Date
August 1 2007
Last Update
November 19 2010
Active Locations (56)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
San Diego, California, United States
2
Research Site
Torrance, California, United States
3
Research Site
Bridgeport, Connecticut, United States
4
Research Site
Atlantis, Florida, United States